Effectiveness of homologous/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three European countries. - Riefolo F; Castillo-Cano B; Martín-Pérez M; Messina D; Elbers R; Brink-Kwakkel D; Villalobos F; Ingrasciotta Y; Garcia-Poza P; Swart-Polinder K; Souverein P; Saiz LC; et al. (Vaccine, 2023)